#chemotherapy — Monday, June 01, 2026 (4 items)
| 0 | ℹ |
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial.
(nature.com)
|
Nature Medicine 2026-06-01 | #cancer #clinical trial #immunotherapy #chemotherapy | |
| 0 | ℹ |
A CHK1-mediated phosphorylation switch suppresses human Topoisomerase 1-associated genomic instability.
(link.springer.com)
|
The EMBO Journal 2026-06-01 | #dna repair #phosphorylation #genomic instability #chemotherapy #topoisomerase | |
| 0 | ℹ |
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.
(nature.com)
|
Nature Medicine 2026-06-01 | #cancer #clinical trial #chemotherapy #transcription factor #ewing sarcoma | |
| 0 | ℹ |
Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer.
(nature.com)
|
Nature 2026-06-01 | #amr #transcriptomics #cancer #chemotherapy #emt |